Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 150

1.

Hyperglycemic conditions inhibit C3-mediated immunologic control of Staphylococcus aureus.

Hair PS, Echague CG, Rohn RD, Krishna NK, Nyalwidhe JO, Cunnion KM.

J Transl Med. 2012 Mar 5;10:35. doi: 10.1186/1479-5876-10-35.

2.

Staphylococcus aureus metalloprotease aureolysin cleaves complement C3 to mediate immune evasion.

Laarman AJ, Ruyken M, Malone CL, van Strijp JA, Horswill AR, Rooijakkers SH.

J Immunol. 2011 Jun 1;186(11):6445-53. doi: 10.4049/jimmunol.1002948. Epub 2011 Apr 18.

3.
4.

Glucose-based dialysis fluids inhibit innate defense against Staphylococcus aureus.

Kumar PS, Mauriello CT, Hair PS, Rister NS, Lawrence C, Raafat RH, Cunnion KM.

Mol Immunol. 2015 Oct;67(2 Pt B):575-83. doi: 10.1016/j.molimm.2015.07.017.

PMID:
26256795
5.

Staphylococcal complement inhibitor modulates phagocyte responses by dimerization of convertases.

Jongerius I, Puister M, Wu J, Ruyken M, van Strijp JA, Rooijakkers SH.

J Immunol. 2010 Jan 1;184(1):420-5. doi: 10.4049/jimmunol.0902865. Epub 2009 Nov 30.

6.

Hyperglycemia inhibits complement-mediated immunological control of S. aureus in a rat model of peritonitis.

Mauriello CT, Hair PS, Rohn RD, Rister NS, Krishna NK, Cunnion KM.

J Diabetes Res. 2014;2014:762051. doi: 10.1155/2014/762051. Epub 2014 Dec 31.

7.

Serum complement factor I decreases Staphylococcus aureus phagocytosis.

Cunnion KM, Buescher ES, Hair PS.

J Lab Clin Med. 2005 Nov;146(5):279-86.

PMID:
16242527
8.

Opsonization of encapsulated Staphylococcus aureus: the role of specific antibody and complement.

Verbrugh HA, Peterson PK, Nguyen BY, Sisson SP, Kim Y.

J Immunol. 1982 Oct;129(4):1681-7.

PMID:
7108223
9.

Bactericidal/permeability-increasing protein promotes complement activation for neutrophil-mediated phagocytosis on bacterial surface.

Nishimura H, Gogami A, Miyagawa Y, Nanbo A, Murakami Y, Baba T, Nagasawa S.

Immunology. 2001 Aug;103(4):519-25.

10.

Role of complement receptors 1 and 2 (CD35 and CD21), C3, C4, and C5 in survival by mice of Staphylococcus aureus bacteremia.

Cunnion KM, Benjamin DK Jr, Hester CG, Frank MM.

J Lab Clin Med. 2004 Jun;143(6):358-65.

PMID:
15192652
11.

A structural basis for complement inhibition by Staphylococcus aureus.

Hammel M, Sfyroera G, Ricklin D, Magotti P, Lambris JD, Geisbrecht BV.

Nat Immunol. 2007 Apr;8(4):430-7. Epub 2007 Mar 11.

PMID:
17351618
13.

Specific serum Ig recognizing staphylococcal wall teichoic acid induces complement-mediated opsonophagocytosis against Staphylococcus aureus.

Jung DJ, An JH, Kurokawa K, Jung YC, Kim MJ, Aoyagi Y, Matsushita M, Takahashi S, Lee HS, Takahashi K, Lee BL.

J Immunol. 2012 Nov 15;189(10):4951-9. doi: 10.4049/jimmunol.1201294. Epub 2012 Oct 15.

14.

The extracellular adherence protein from Staphylococcus aureus inhibits the classical and lectin pathways of complement by blocking formation of the C3 proconvertase.

Woehl JL, Stapels DAC, Garcia BL, Ramyar KX, Keightley A, Ruyken M, Syriga M, Sfyroera G, Weber AB, Zolkiewski M, Ricklin D, Lambris JD, Rooijakkers SHM, Geisbrecht BV.

J Immunol. 2014 Dec 15;193(12):6161-6171. doi: 10.4049/jimmunol.1401600. Epub 2014 Nov 7.

15.

Capsule production and growth phase influence binding of complement to Staphylococcus aureus.

Cunnion KM, Lee JC, Frank MM.

Infect Immun. 2001 Nov;69(11):6796-803.

16.

Analysis of C3 deposition and degradation on bacterial surfaces after opsonization.

Gordon DL, Rice J, Finlay-Jones JJ, McDonald PJ, Hostetter MK.

J Infect Dis. 1988 Apr;157(4):697-704.

PMID:
3279137
17.

Surface Glycopolymers Are Crucial for In Vitro Anti-Wall Teichoic Acid IgG-Mediated Complement Activation and Opsonophagocytosis of Staphylococcus aureus.

Lee JH, Kim NH, Winstel V, Kurokawa K, Larsen J, An JH, Khan A, Seong MY, Lee MJ, Andersen PS, Peschel A, Lee BL.

Infect Immun. 2015 Nov;83(11):4247-55. doi: 10.1128/IAI.00767-15. Epub 2015 Aug 17.

18.

Serum heat-labile opsonins in systemic lupus erythematosus.

Jasin HE, Orozco JH, Ziff M.

J Clin Invest. 1974 Feb;53(2):343-53.

19.

Mannose-binding lectin (MBL) facilitates opsonophagocytosis of yeasts but not of bacteria despite MBL binding.

Brouwer N, Dolman KM, van Houdt M, Sta M, Roos D, Kuijpers TW.

J Immunol. 2008 Mar 15;180(6):4124-32.

20.

Characterization of the mechanism of protection mediated by CS-D7, a monoclonal antibody to Staphylococcus aureus iron regulated surface determinant B (IsdB).

Pancari G, Fan H, Smith S, Joshi A, Haimbach R, Clark D, Li Y, Hua J, McKelvey T, Ou Y, Drummond J, Cope L, Montgomery D, McNeely T.

Front Cell Infect Microbiol. 2012 Mar 20;2:36. doi: 10.3389/fcimb.2012.00036. eCollection 2012.

Supplemental Content

Support Center